These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10397789)

  • 1. Addition of positively charged tripeptide to N-terminus of the Fos basic region leucine zipper domain: implications on DNA bending, affinity, and specificity.
    Mahmoudi T; Sarkar B
    Biopolymers; 1999 Sep; 50(3):273-86. PubMed ID: 10397789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA.
    Harford C; Narindrasorasak S; Sarkar B
    Biochemistry; 1996 Apr; 35(14):4271-8. PubMed ID: 8605175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR; Kerppola TK
    J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
    Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
    Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a sensitive peptide-based immunoassay: application to detection of the Jun and Fos oncoproteins.
    Heuer KH; Mackay JP; Podzebenko P; Bains NP; Weiss AS; King GF; Easterbrook-Smith SB
    Biochemistry; 1996 Jul; 35(28):9069-75. PubMed ID: 8703910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coupling of folding and DNA-binding in the bZIP domains of Jun-Fos heterodimeric transcription factor.
    Seldeen KL; McDonald CB; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 May; 473(1):48-60. PubMed ID: 18316037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine zippers of fos, jun and GCN4 dictate dimerization specificity and thereby control DNA binding.
    Kouzarides T; Ziff E
    Nature; 1989 Aug; 340(6234):568-71. PubMed ID: 2505081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behind the Fos and Jun leucine zipper.
    Kouzarides T; Ziff E
    Cancer Cells; 1989 Nov; 1(3):71-6. PubMed ID: 2518283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoiling c-Jun coiled coils: inhibitory effects of truncated Fos peptides on Jun dimerization and DNA binding in vitro.
    Yao S; Brickner M; Pares-Matos EI; Chmielewski J
    Biopolymers; 1998; 47(4):277-83. PubMed ID: 10036969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a high-affinity DNA pool for a bZip protein with an out-of-phase alignment of the basic region relative to the leucine zipper.
    Lee Y; Gurnon DG; Hollenbeck JJ; Oakley MG
    Bioorg Med Chem; 2001 Sep; 9(9):2335-9. PubMed ID: 11553473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. fos and jun interaction: the role of the leucine zipper.
    Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
    Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of DNA bending by Fos-Jun and phased A tracts by multifactorial phasing analysis.
    Kerppola TK
    Biochemistry; 1997 Sep; 36(36):10872-84. PubMed ID: 9283077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat maf-related factors: the specificities of DNA binding and heterodimer formation.
    Matsushima-Hibiya Y; Nishi S; Sakai M
    Biochem Biophys Res Commun; 1998 Apr; 245(2):412-8. PubMed ID: 9571165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Fos protein containing the Jun leucine zipper forms a homodimer which binds to the AP1 binding site.
    Neuberg M; Adamkiewicz J; Hunter JB; Müller R
    Nature; 1989 Sep; 341(6239):243-5. PubMed ID: 2506451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.